Prostrakan to acquire distressed assets


Scotland-headquartered pharmaceutical firm Prostrakan has drawn down £5 million from an agreed £50 million loan facility to snap up distressed assets

Marc Barber

Marc Barber

Marc was editor of GrowthBusiness from 2006 to 2010. He specialised in writing about entrepreneurs, private equity and venture capital, mid-market M&A, small caps and high-growth businesses.

Related Topics

Early Stage Funding